Kilpest India, an agri-based company, on Tuesday announced the sales update for the month ending November, 2020. The company has sold 6,10,100 COVID19 RT-PCR Tests in the month of November, 2020 with an average price of Rs. 148 per test.

Further, the company applied and got license to export the long pending orders mainly for non-COVID kits and exported for Rs. 65,00,000. Thereafter the restrictions continue till further license window opens, it said.

Shares of Kilpest India  are trading at Rs 340.60, down Rs 17.9, or 4.99%  at the Bombay Stock Exchange (BSE) on Tuesday at 3:20 p.m.

The scrip has touched an intra-day high of Rs 367.80 and low of Rs 340.60. The total volume of shares traded at the BSE is 62,536.

In the earlier session, the shares climbed 4.2%, or Rs 14.45, at Rs 358.50.

The stock hit its 52-week high of Rs 517 on Aug. 08, 2020 and 52-week low of Rs 54 on Mar.13, 2020.